Document is current
Any future updates will be listed below
-
Authors
Moccia, Marialuisa
Yang, Donglin
Lakkaniga, Naga Rajiv
Frett, Brendan
McConnell, Nicholas
Zhang, Lingtian
Brescia, Annalisa
Federico, Giorgia
Zhang, Lingzhi
Salerno, Paolo
Santoro, Massimo
Li, Hong-yu
Carlomagno, Francesca
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 20793)
Associazione Italiana per la Ricerca sul Cancro (IG 20793)
Associazione Italiana per la Ricerca sul Cancro (IG 20793)
Associazione Italiana per la Ricerca sul Cancro (IG 20793)
National Institutes of Health (1R01CA197178)
National Institutes of Health (1R01CA194094)
National Institutes of Health (1R01CA194094)
National Institutes of Health (1R01CA197178)
National Institutes of Health (1R01CA197178)
National Institutes of Health (1R01CA194094)
University of Arkansas for Medical Sciences (Start up)
University of Arkansas for Medical Sciences (Start up)
University of Arkansas for Medical Sciences (Start up)
- License Information
-
More Information
Article History
Received: 3 November 2020
Accepted: 20 July 2021
First Online: 9 August 2021
Competing interests
: B. Frett and H.Y. Li have ownership interest in Synactix Pharmaceuticals, Inc. F. Carlomagno, B. Frett, M. Santoro, and H.Y. Li are inventors of patent WO/2015/187818. The other authors have no conflict of interest.
